Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
Open Access
- 24 June 2017
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. XX (XX), 1-11
- https://doi.org/10.14218/jcth.2017.00009
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a burgeoning global health concern. In the subset of NAFLD patients with non-alcoholic steatohepatitis (NASH), the presence of significant fibrosis at index assessment is associated with poor prognosis and increased mortality. Hence, there is a growing need to accurately assess and stage fibrosis. Liver biopsy, the current gold standard, has limitations with sampling error and is invasive, with associated inherent risk. This has led to a host of non-invasive means of assessing fibrosis, which has garnered relevance in a disease that requires serial assessment of fibrosis longitudinally over time. This review discusses, comprehensively, the various tools available to the clinician for the assessment of fibrosis, including the various scoring systems used in liver biopsy, the non-invasive means of serum biomarkers, such as the highly-validated NAFLD fibrosis score, and the imaging-based modalities, such as transient elastography and magnetic resonance elastography.Keywords
This publication has 111 references indexed in Scilit:
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and EuropeJournal of Hepatology, 2016
- Natural History of Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesJournal of Hepatology, 2015
- Nonalcoholic fatty liver disease and cardiovascular diseaseWorld Journal of Gastroenterology, 2014
- The global NAFLD epidemicNature Reviews Gastroenterology & Hepatology, 2013
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary teamJournal of Hepatology, 2013
- NAFLD in Asia—as common and important as in the WestNature Reviews Gastroenterology & Hepatology, 2013
- Increased overall mortality and liver-related mortality in non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- Long-term follow-up of patients with NAFLD and elevated liver enzymesJournal of Hepatology, 2006
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyGastroenterology, 2005